Complimentary On-Demand Webinar

Digital vs Digitized: Common misconceptions about eConsent

With Nature stating that almost 60% of clinical professionals expect eConsent adoption to continue post-pandemic, it is clear the benefits behind a digitally-enabled consent process have garnered trust. But a recent Medable poll found that the informed consent process still remains rooted in paper. This reliance on paper comes at a cost though: low enrollment, poor patient retention and issues around site compliance leading to inspection findings and costly trial delays.

In this on-demand webinar, you will learn:

  • Common myths that continue to persist around eConsent
  • How to improve comprehension with patient-centric consent
  • How to use a digital consent management tool to improve trial compliance, quality and oversight

Watch On-Demand

A Digitally-enabled Approach

Listen in as experts from Medable and Vertex discuss some of the common misconceptions surrounding eConsent, from requiring expensive provisioned devices and complex digital consent forms to limitations when deploying globally, as well as highlighting the benefits that can be realized by adopting a digitally-enabled approach to patient consent. 
Our speakers:

Vice President & General Manager, eConsent at Medable

Clinical Technology Innovations Principal at Vertex Pharmaceuticals.

A man using an iPad on his lap.

A Digitally-enabled Approach

Listen in as experts from Medable and Vertex discuss some of the common misconceptions surrounding eConsent, from requiring expensive provisioned devices and complex digital consent forms to limitations when deploying globally, as well as highlighting the benefits that can be realized by adopting a digitally-enabled approach to patient consent. 
Our speakers:

Vice President & General Manager, eConsent at Medable

Clinical Technology Innovations Principal at Vertex Pharmaceuticals.